Reuters logo
4 months ago
BRIEF-Immunomedics reports preclinical study presented at 2017 AACR annual meeting
April 4, 2017 / 12:35 PM / 4 months ago

BRIEF-Immunomedics reports preclinical study presented at 2017 AACR annual meeting

1 Min Read

April 4 (Reuters) - Immunomedics Inc:

* Immunomedics reports immu-132 delivers high levels of sn-38 that overcome chemoresistant tumors with moderate to strong trop-2 expression Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below